by European Public Health Alliance | Oct 28, 2022 | Opinion
By Tom Buis, Global Health Advocate at Wemos Now more than ever is the time to advocate together for structural solutions to achieve equitable access to medical products. In the upcoming months, member states of the World Health Organization (WHO) will start the...
by European Public Health Alliance | Oct 28, 2022 | Opinion
By Stephanie Kohl, Policy & Advocacy Officer at the European Association of Hospital Pharmacists (EAHP) Providing equal and timely access for all patients, including those with rare conditions and unmet needs, to all relevant medicinal therapies is one of the...
by European Public Health Alliance | Oct 28, 2022 | Opinion
By Dr Ward Rommel, Chair, Access to Medicines Task Force, Association of European Cancer Leagues (ECL) – @CancerLeagues & @WardRommel | #LetsTalkAccess If you have cancer and you need medicine, you should be able to get it. Everyone agrees but, sadly,...
by European Public Health Alliance | Oct 28, 2022 | Opinion
In June 2022, the members of the European Alliance for Responsible R&D and Affordable Medicines gathered in Rome to analyse the current public health scene and discuss potential solutions to the most prominent challenges. In light of public health outbreaks in the...
by European Public Health Alliance | Oct 26, 2022 | Opinion
Article by Paul Belcher, EPHA Special Advisor The fresh mountain air of Gastein brought some welcome new thinking and energising discussions on the theme of “A moonshot for a true European Health Union”, but it also highlighted that some key public health topics...
by European Public Health Alliance | Oct 26, 2022 | Opinion
Or can the European Health Union become a place for people, governments and the private sector to support an economy no longer based on GDP growth? Acutely quiet amidst the perfect storm We are facing an unprecedented existential crisis, there is no disagreement...
